Health Care Cost

Latest News

The first gene therapies for sickle cell disease were FDA approved in 2023, but high upfront costs have been barriers to patient access to these life-changing treatments. | Image credit: RFBSIP - stock.adobe.com
CGT Access Model Aims to Expand Access to Sickle Cell Treatments

July 18th 2025

States participating in the Cell and Gene Therapy (CGT) Access Model will be testing outcomes-based payments for sickle cell disease treatments.

AJMC
Assertive Community Treatment for Complex and Costly Patients

July 18th 2025

AI Meets Medicare: Inside CMS’ WISeR Model With Sanjay Doddamani, MD, MBA
AI Meets Medicare: Inside CMS’ WISeR Model With Sanjay Doddamani, MD, MBA

July 17th 2025

HHS headquarters | Image credit: Tada Images - stock.adobe.com
MFN Drug Pricing: Risks to Access, Affordability, and Innovation in Health Care

July 16th 2025

Rise in drug pricing | Image Credit: Alex Puhovoy - stock.adobe.com
Medicare Inflation Rebates Show Limited Impact on Drug Price Trends

July 14th 2025

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo